Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Aadi Bioscience (AADI) has provided an update.
Loretta Itri, M.D., is stepping down as Chief Medical Officer but will receive a generous severance package and maintain a consulting role with her former company. Neil Desai, Ph.D., also plans to leave his role as Executive Chairman, with a severance in line with his agreement. Both will continue their involvement with the company, Itri through consulting and Desai as a board member, allowing them to retain their equity awards. This move could signal strategic shifts or a refresh in leadership, offering potential impacts on the company’s direction and stock performance.
For a thorough assessment of AADI stock, go to TipRanks’ Stock Analysis page.